Literature DB >> 4092240

Failure of nimodipine to reverse acute experimental spinal cord injury.

R W Ford, D N Malm.   

Abstract

The calcium-channel blocking agent, nimodipine, was administered to cats for 5 days after acute experimental SCI. Six weeks after injury, no significant differences in neurologic recovery or white matter tissue preservation at the injury site were found between treated and control animals.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4092240     DOI： 10.1089/cns.1985.2.9

Source DB:  PubMed          Journal:  Cent Nerv Syst Trauma        ISSN： 0737-5999


  6 in total

1.  The effects of chronic alpha-tocopherol administration on lipid peroxidation in an experimental model of acute spinal cord injury.

Authors:  M Bozbuğa; N Izgi; A Canbolat
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

Review 2.  Current and future medical therapeutic strategies for the functional repair of spinal cord injury.

Authors:  Tevfik Yılmaz; Erkan Kaptanoğlu
Journal:  World J Orthop       Date:  2015-01-18

3.  IP3R-mediated intra-axonal Ca2+ release contributes to secondary axonal degeneration following contusive spinal cord injury.

Authors:  Ben C Orem; Arezoo Rajaee; David P Stirling
Journal:  Neurobiol Dis       Date:  2020-10-01       Impact factor: 5.996

Review 4.  Chemical priming for spinal cord injury: a review of the literature part II-potential therapeutics.

Authors:  Martin M Mortazavi; Ketan Verma; Aman Deep; Fatemeh B Esfahani; Patrick R Pritchard; R Shane Tubbs; Nicholas Theodore
Journal:  Childs Nerv Syst       Date:  2010-12-21       Impact factor: 1.475

5.  Effect of nimodipine and N-acetylcysteine on lipid peroxidation after experimental spinal cord injury.

Authors:  M Y Kaynar; P Erdinçler; E Tadayyon; A Belce; K Gümüstas; N Ciplak
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

6.  Inhibiting Calcium Release from Ryanodine Receptors Protects Axons after Spinal Cord Injury.

Authors:  Ben C Orem; Arezoo Rajaee; David P Stirling
Journal:  J Neurotrauma       Date:  2022-02       Impact factor: 5.269
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.